MktsMarkets

Mangoceuticals, Inc.
NASDAQ: MGRXKey statistics
MGRX News
Stories mentioning MGRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 68.00 | 95.00 | 84.00 | 168.00 | 109.00 | 106.00 | 133.00 | 163.00 |
| Cost of Goods Sold | 8.00 | 8.00 | 2.00 | 19.00 | 25.00 | 20.00 | 22.00 | 30.00 |
| Gross Profit | 29.00 | 47.00 | 51.00 | 90.00 | 62.00 | 80.00 | 83.00 | 70.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 3,155 | 693.00 | 7,594 | 5,358 | 4,638 | 1,758 | 1,841 | 2,238 |
| Operating Income (Loss) | (3,126) | (645.00) | (7,543) | (5,268) | (4,576) | (1,677) | (1,758) | (2,169) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (3,403) | (2,769) | (7,619) | (5,416) | (4,839) | (1,948) | (2,000) | (2,391) |
| Tax Provision | ||||||||
| Net Income (Loss) | (3,403) | (2,770) | (7,618) | (5,416) | (4,839) | (1,948) | (1,999) | (2,391) |
| Earnings Per Share (Basic) | (0.22) | 0.21 | (0.69) | (0.57) | (1.12) | (0.98) | (1.14) | (1.37) |
| Earnings Per Share (Diluted) | (0.22) | (0.28) | (0.69) | (0.57) | (1.12) | (0.98) | (1.14) | (1.37) |
| Weighted Average Shares Outstanding (Basic) | 16,482 | 11,524 | 4,593 | 1,979 | 2,014 | 1,740 | ||
| Weighted Average Shares Outstanding (Diluted) | 16,482 | 10,072 | 11,524 | 9,983 | 4,593 | 1,979 | 2,014 | 1,740 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MGRX
Mangoceuticals, Inc. (NASDAQ: MGRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol MGRX. It last traded at $0.1500 (Nov 18, 2026, 2:50 PM ET), down 9.0% on the day. That gives Mangoceuticals a market capitalisation of $3.6M.
Over the past 52 weeks MGRX has traded between $0.1500 and $1.39.
Revenue for the quarter ended Mar 31, 2026 was $68.0K; a net loss of $3.4M. Revenue was down 37.6% from $109.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $68.0K | -$3.4M | -5004.4% |
| Dec 31, 2025 | $95.0K | -$2.8M | -2915.8% |
| Sep 30, 2025 | $84.0K | -$7.6M | -9069.0% |
| Jun 30, 2025 | $168.0K | -$5.4M | -3223.8% |
From Mangoceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…